Gene · 563
Papers1,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Albumin-Mediated Size Exclusion Chromatography: The Apparent Molecular Weight of PSMA Radioligands as Novel Parameter to Estimate Their Blood Clearance Kinetics. | Pharmaceuticals (Basel) | 2022 | 36145382 | PubTator, text mining | PubMed |
| Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Lung Cancer. | Int J Mol Sci | 2022 | 36142846 | PubTator, text mining | PubMed |
| The evolving view of thermogenic fat and its implications in cancer and metabolic diseases. | Signal Transduct Target Ther | 2022 | 36114195 | PubTator, text mining | PubMed |
| Transcriptional sequencing analysis reveals the potential use of deer antler for "tonifying the kidney and strengthening bone". | J Orthop Surg Res | 2022 | 36104709 | PubTator, text mining | PubMed |
| A comparative proteomic study of high and low semen quality seminal plasma in drakes. | Poult Sci | 2022 | 36088822 | PubTator, text mining | PubMed |
| Seminal Plasma Glycoproteins as Potential Ligands of Lectins Engaged in Immunity Regulation. | Int J Environ Res Public Health | 2022 | 36078205 | PubTator, text mining | PubMed |
| Browning of the white adipose tissue regulation: new insights into nutritional and metabolic relevance in health and diseases. | Nutr Metab (Lond) | 2022 | 36068578 | PubTator, text mining | PubMed |
| Identification of key genes and pathways in chronic rhinosinusitis with nasal polyps and asthma comorbidity using bioinformatics approaches. | Front Immunol | 2022 | 36059464 | PubTator, text mining | PubMed |
| Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy. | Nat Commun | 2022 | 36057605 | PubTator, text mining | PubMed |
| The prognostic value of immune-related genes AZGP1, SLCO5A1, and CTF1 in Uveal melanoma. | Front Oncol | 2022 | 36052234 | PubTator, text mining | PubMed |
| Association between serum zinc level and lipid profiles in children with spinal muscular atrophy. | Front Nutr | 2022 | 36046135 | PubTator, text mining | PubMed |
| High Level of Irisin as a Marker of Malnutrition in Head and Neck Cancer Patients Subjected to Radiotherapy. | Med Sci Monit | 2022 | 36045563 | PubTator, text mining | PubMed |
| Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast Cancer. | Clin Cancer Res | 2022 | 36043530 | PubTator, text mining | PubMed |
| Identification of a pyroptosis-related lncRNA signature in the regulation of prognosis, metabolism signals and immune infiltration in lung adenocarcinoma. | Front Endocrinol (Lausanne) | 2022 | 36034461 | PubTator, text mining | PubMed |
| A systematic review and Meta-analysis of urinary extracellular vesicles proteome in diabetic nephropathy. | Front Endocrinol (Lausanne) | 2022 | 36034457 | PubTator, text mining | PubMed |
| Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing. | Vaccines (Basel) | 2022 | 36016137 | PubTator, text mining | PubMed |
| Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson's Disease. | Int J Mol Sci | 2022 | 36012563 | PubTator, text mining | PubMed |
| Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine. | Cancers (Basel) | 2022 | 36010869 | PubTator, text mining | PubMed |
| Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives. | Biomedicines | 2022 | 36009535 | PubTator, text mining | PubMed |
| Human Blood Serum Inhibits Ductal Carcinoma Cells BT474 Growth and Modulates Effect of HER2 Inhibition. | Biomedicines | 2022 | 36009461 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/563/papers?page=16